rheumatology

Welcome to the 'rheumatology' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'rheumatology'.

Latest blogosphere posts tagged “rheumatology”

• Is There A Blood Test For Rheumatoid Arthritis?

  
  Healthy Living Times — Authority: 137
  Rheumatoid arthritis (RA) is the most common inflammatory form of arthritis. It affects roughly 2 million Americans. It is a chronic, systemic, autoimmune disorder for which there is no known cure. However, there are very effective medicine regimens that can control the disease and get it into remission. The major ...
  6 hours ago

• Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money

  
  Xconomy — Authority: 712
  Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...
  20 hours ago

• Judgement In Favour Of NICE On Judicial Review Of Abatacept For Rheumatoid Arthritis Guidance

  
  Health News from Medical News Today — Authority: 738
  The High Court has ruled in favour of NICE by dismissing the application from Bristol Myers Squibb (BMS), the manufacturer of abatacept, for a judicial review of the NICE guidance on the use of abatacept for the treatment of rheumatoid arthritis. In April 2008, NICE published final guidance which did not recommend ...
  1 day ago

• Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion

  
  Xconomy — Authority: 712
  Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...
  1 day ago

• MorphoSys Receives Regulatory Approval To Start Phase 1b/2a Clinical Trial For MOR103 Program

  
  Health News from Medical News Today — Authority: 738
  Germanys Paul-Ehrlich-Institute Approves Clinical Trial in Rheumatoid Arthritis Patients MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that it has received clearance from Germanys Paul-Ehrlich-Institute as well as a positive opinion from the ethics committees in Germany
  2 days ago

• What’s The Most Expensive Medical Condition?

  
  Better Health — Authority: 600
  What medical condition costs the U.S. Health system the most in disability and overall costs? If you said heart disease or cancer or pulmonary disease you would be wrong! I would have said one of those myself. The answer…slow drumroll….is musculoskeletal disease . Yes, 50% of the adult population reported ...
  1 week ago

• Link Between Childhood Physical Abuse And Arthritis

  
  Health News from Medical News Today — Authority: 738
  Adults who had experienced physical abuse as children have 56 per cent higher odds of osteoarthritis compared to those who have not been abused, according to a new study by University of Toronto researchers. University of Toronto researchers investigated the relationship between self-reported childhood physical ...
  1 week ago

• New & Interesting (2 November 2009)

  
  On The Wards — Authority: 106
  The “New & Interesting” series is a biweekly compilation of select research findings, news articles, and random tidbits in bullet-point format. The entries are highly abbreviated, but provide links to the original articles or abstracts if you desire to read further.General ArticlesVideo games may cause kids to ...
  1 week ago

• Second Belimumab Trial Delivers, Sort Of

  
  Pathophilia — Authority: 468
  Another phase 3 trial of belimumab (Benlysta; Human Genome Sciences/GSK) in patients with systemic lupus erythematosus (SLE) has met its primary endpoint, according to a company press release. These data complement results of a previous phase 3 study, BLISS-52,...
  1 week ago

• New Tool To Accelerate Discovery Of Autoimmune Disease Mechanisms And Therapies

  
  Health News from Medical News Today — Authority: 738
  Currently, 5 - 8% of the U.S. population is afflicted with an autoimmune disease. Many of these are chronic and require life-long care. Moreover, different autoimmune diseases aggregate within a single family, suggesting they are caused by disruptions in common biological pathways.
  1 week ago

• Tai Chi Exercise Reduces Knee Osteoarthritis Pain In The Elderly

  
  Health News from Medical News Today — Authority: 738
  Researchers from Tufts University School of Medicine have determined that patients over 65 years of age with knee osteoarthritis (OA) who engage in regular Tai Chi exercise improve physical function and experience less pain.
  1 week ago

• Link Between Pain Thresholds, Inflammation And Sleep Problems In Arthritis Patients

  
  Health News from Medical News Today — Authority: 738
  Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain.
  1 week ago

• UK Trust Sues Amgen & Wyeth Over Enbrel Patent

  
  Pharmalot — Authority: 589
  The Mathilda and Terence Kennedy Institute of Rheumatology Trust filed its lawsuit in federal court in Delaware, seeking royalties and damages from Wyeth and Amgen for infringing a patent for treating arthritis. The drug makers jointly market Enbrel, a best-selling med, for treating rheumatoid arthritis. In its ...
  2 weeks ago

• Advancing Personalized Medicine In Rheumatoid Arthritis

  
  Health News from Medical News Today — Authority: 738
  The University of Alabama at Birmingham (UAB) is spearheading an effort to create a national database and repository to enable researchers to identify predictors of effectiveness of various treatments for rheumatoid arthritis (RA). RA is the most common type of inflammatory arthritis.
  2 weeks ago

• UAB Creates National Network To Advance Personalized Medicine In Rheumatoid Arthritis

  
  Health News from Medical News Today — Authority: 738
  The University of Alabama at Birmingham (UAB) is spearheading an effort to create a national database and repository to enable researchers to identify predictors of effectiveness of various treatments for rheumatoid arthritis (RA). RA is the most common type of inflammatory arthritis.
  2 weeks ago

• TNF-Alpha Inhibitors Will Continue To Dominate First- And Second-Line Biologic Therapy For The Treatment Of Rheumatoid Arthritis Through 2011

  
  Health News from Medical News Today — Authority: 738
  Decision Resources, one of the worlds leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the Unite
  2 weeks ago

• Therapeutic Advances In Musculoskeletal Disease Launched By SAGE

  
  Health News from Medical News Today — Authority: 738
  SAGE has announced the launch of Therapeutic Advances in Musculoskeletal Disease, the latest in SAGEs highly-regarded Therapeutic Advances series. Therapeutic Advances in Musculoskeletal Disease is for all professionals concerned with research into, and the practice of, musculoskeletal disease and is a forum for ...
  2 weeks ago

• FDA Approves New Test To Aid In The Diagnosis Of Rheumatoid Arthritis

  
  Health News from Medical News Today — Authority: 738
  An important assay used to aid in the diagnosis of rheumatoid arthritis (RA) will soon be available on Abbotts ARCHITECT immunoassay analyzers. The FDA has granted 510(k) clearance for an antibody cyclic-citrulinated peptide, or anti-CCP assay, to run on the world class systems.
  2 weeks ago

• So thats what that slide does.

  
  ACP Internist — Authority: 503
  The disclosure slide has become a standard feature of medical lectures. A good percentage of the time speakers disclose nothing, or something silly like their love of the Yankees. But yesterday, at the ACR meeting, I saw a disclosure slide that even the speaker himself described as "very conflicted." This doctor was ...
  3 weeks ago

• ARTRITE REUMATOIDE: TRATTAMENTO RIPETUTO CON RITUXIMAB CONTROLLA LA MALATTIA

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  I nuovi dati presentati al congresso annuale dell’American College of Rheumatology (ACR) suggeriscono che i pazienti affetti da artrite reumatoide (AR), trattati con rituximab, debbano essere valutati ogni sei mesi e sottoposti ad un nuovo trattamento se non sono in remissione. I dati dimostrano che questo approccio ...
  3 weeks ago

Comments about rheumatology